KnowledgeBase

• Home
• Antimicrobials
• Microorganisms
• About Us
• Contact Us

• Search All
• Search by Antimicrobial
• Search by Microorganism
• 

Home › Search by Microorganism › Staphylococcus spp. (CL 8638 + coagulase-negative + tetracycline-resistant)

• Staphylococcus spp.
• Staphylococcus spp. (CL 12557 + coagulase-negative)
• Staphylococcus spp. (CL 12771 + coagulase-negative + methicillin-susceptible)
• Staphylococcus spp. (CL 14084 + coagulase-negative + methicillin-resistant + macrolide-resistant)
• Staphylococcus spp. (CL 8040 + coagulase-negative + methicillin-resistant)
• Staphylococcus spp. (CL 8341 + coagulase-negative)
• Staphylococcus spp. (CL 8520 + coagulase-negative + methicillin-resistant + tetracycline-resistant)
• Staphylococcus spp. (CL 8638 + coagulase-negative + tetracycline-resistant)
• Staphylococcus spp. (CL 8952 + coagulase-negative + methicillin-resistant)
• Staphylococcus spp. (coagulase negative)
• Staphylococcus spp. (coagulase-negative + clindamycin-resistant)
• Staphylococcus spp. (coagulase-negative + methicillin-resistant)
• Staphylococcus spp. (coagulase-negative + methicillin-susceptible)
• Staphylococcus spp. (coagulase-negative + oxacillin-resistant)
• Staphylococcus spp. (coagulase-negative + oxacillin-susceptible)
• Staphylococcus spp. (coagulase-negative)
• Staphylococcus spp. (glycopeptide-intermediate)
• Staphylococcus spp. (methicillin-resistant)
• Staphylococcus spp. (meticillin-resistant)
• Staphylococcus spp. (serogroup C)
• Staphylococcus spp. (serogroup F)
• Staphylococcus spp. (serogroup G)
• Staphylococcus spp. (vancomycin-intermediate + includes USA, Europe, and Japan)

This project is supported by TOKU-E which specializes in manufacturing ultra-pure antibiotics for a broad spectrum of biotechnology applications as well as for the pharmaceutical industry. TOKU-E is a global leader in biotechnology innovation, offering great benefits and applications to the biopharmaceutical and diagnostic industries as well as for biotechnology research communities.
Privacy Policy | Terms of Use
Knowledgebase version 1.8